News | 17 August 2012
A shortage of injectable drugs in the U.S. means India's Strides Arcolab Ltd. (STR) could sell a division that makes generic cancer treatments and antibiotics for more than the entire company's market value. Strides, which has seen its market ...
Click on the link to read the full article at Bloomberg
(This link will open in a new window)